Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.59%5.11B | -17.95%1.12B | -15.94%1.26B | -12.30%5.53B | -19.78%1.28B | -12.45%1.39B | -13.74%1.36B | -2.97%1.5B | 51.46%6.31B | 48.16%1.6B |
| Cost of revenue | -0.09%2.35B | -21.04%468.21M | -15.43%517.74M | -14.98%2.35B | -29.67%551.33M | -5.93%594.52M | -13.26%592.95M | -8.04%612.21M | 50.48%2.77B | 71.30%783.96M |
| Gross profit | -13.14%2.76B | -15.57%648.91M | -16.30%744.6M | -10.21%3.18B | -10.23%729.49M | -16.79%791.46M | -14.12%768.58M | 0.86%889.56M | 52.23%3.54B | 31.08%812.66M |
| Operating expense | -7.28%3.04B | -7.18%746.53M | -12.56%746M | -13.57%3.28B | -13.72%800.48M | -8.08%824.17M | -20.10%804.31M | -11.73%853.15M | 51.34%3.8B | 41.61%927.8M |
| Operating profit | -173.79%-282.04M | -173.23%-97.62M | -103.86%-1.41M | 59.89%-103.01M | 38.35%-70.99M | -159.93%-32.71M | 68.01%-35.73M | 143.05%36.41M | -40.05%-256.82M | -226.71%-115.14M |
| Net non-operating interest income (expenses) | -175.61%-68.32M | -129.57%-5.27M | -813.90%-13.75M | -167.74%-24.79M | -554.38%-18.66M | -18.27%-2.32M | -2.09%-2.3M | 31.39%-1.5M | -1,873.99%-9.26M | -1,660.49%-2.85M |
| Non-operating interest income | ---- | 2,600.00%54K | --0 | -33.33%4K | 0.00%2K | --0 | -50.00%2K | --0 | -97.97%6K | -92.00%2K |
| Non-operating interest expense | 11.25%9.94M | -9.49%2.08M | 47.41%2.22M | -3.58%8.93M | -1.68%2.81M | 18.27%2.32M | 2.00%2.3M | -31.39%1.5M | 1,110.98%9.26M | 1,426.20%2.85M |
| Total other finance cost | 268.20%58.38M | --3.25M | --11.53M | --15.86M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 41.61%-2.48M | 161.72%1.18M | -13.48%-1.8M | 61.33%-4.25M | -100.94%-25K | -229.13%-727K | 65.77%-1.91M | 81.61%-1.59M | -3,333.53%-10.99M | 1,530.67%2.66M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 19.69%-128.44M | 900K | 0 | -6,085.59%-159.94M | -16,372.59%-158.5M | -647.35%-36.35M | 0 | 432.02%34.91M | -99.19%2.67M | 101.23%974K |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 93.20%-27.04M | ---16.45M |
| Less:Other special charges | 363.57%66.47M | ---- | ---- | -316.58%-25.22M | -75.76%666K | --9.02M | --0 | ---34.91M | 27.73%11.65M | -87.05%2.75M |
| Less:Write off | -66.54%61.96M | ---- | ---- | 1,355.17%185.16M | 1,140.40%157.83M | --27.33M | ---- | ---- | -78.10%12.72M | --12.72M |
| Other non-operating income (expenses) | 100.85%7.33M | 188.62%2M | -103.59%-212K | -86.30%3.65M | -332.69%-2.65M | -361.95%-296K | -93.10%694K | -61.50%5.9M | -21.88%26.64M | -86.82%1.14M |
| Income before tax | -64.37%-473.93M | -151.79%-98.81M | -123.15%-17.16M | -16.38%-288.34M | -121.53%-250.82M | -249.52%-72.4M | 64.15%-39.24M | 200.85%74.13M | -230.68%-247.76M | -6.91%-113.22M |
| Income tax | 27.63%56.75M | -19.14%11.08M | -19.21%11.07M | -18.60%44.46M | -68.47%3.35M | -6.53%13.7M | -6.54%13.7M | -6.53%13.7M | 309.45%54.62M | 463.05%10.64M |
| Net income | -59.46%-530.68M | -107.56%-109.89M | -146.73%-28.24M | -10.06%-332.8M | -105.22%-254.17M | -355.05%-86.11M | 57.34%-52.94M | 168.53%60.43M | -271.56%-302.38M | -14.90%-123.86M |
| Net income continuous operations | -59.46%-530.68M | -107.55%-109.89M | -146.73%-28.24M | -10.06%-332.8M | -105.22%-254.17M | -355.06%-86.11M | 57.34%-52.95M | 168.54%60.43M | -271.56%-302.38M | -14.90%-123.86M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -59.46%-530.68M | -107.56%-109.89M | -146.73%-28.24M | -10.06%-332.8M | -105.22%-254.17M | -355.05%-86.11M | 57.34%-52.94M | 168.53%60.43M | -271.56%-302.38M | -14.90%-123.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -59.46%-530.68M | -107.56%-109.89M | -146.73%-28.24M | -10.06%-332.8M | -105.22%-254.17M | -355.05%-86.11M | 57.34%-52.94M | 168.53%60.43M | -271.56%-302.38M | -14.90%-123.86M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -13.61%-131.16 | -51.09%-27.74 | -135.26%-7.39 | -10.06%-115.45 | -105.21%-88.18 | -355.08%-29.87 | 57.35%-18.36 | 168.52%20.96 | -271.57%-104.9 | -14.89%-42.97 |
| Diluted earnings per share | -13.61%-131.16 | -51.04%-27.74 | -135.26%-7.39 | -10.06%-115.45 | -105.21%-88.18 | -355.08%-29.87 | 57.34%-18.3662 | 168.52%20.96 | -271.57%-104.9 | -14.89%-42.97 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |